Assessing diabetes risk in cirrhosis patients before and after liver transplant
Official title: Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
Run by University of Chicago · NCT06950788 · Data updated 2026-11-12
This study is trying to find out what factors might lead to diabetes in adults with liver cirrhosis before and after they get a liver transplant.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | March 12, 2024 |
| Main results expected | June 2027 |
| Study ends | January 2031 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT06950788 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with a diagnosis of cirrhosis who are being evaluated for liver transplantation.
✕Probably not a fit
Patients with a history of type 2 diabetes diagnosed more than five years ago will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify risk factors for developing diabetes in adult patients with cirrhosis who are being evaluated for liver transplantation. Participants will undergo various assessments, including continuous glucose monitoring, wrist actigraphy, and oral glucose tolerance tests, both prior to and following their liver transplant. The study will track these patients over a five-year period to evaluate the long-term outcomes related to diabetes development. The goal is to determine if specific laboratory and functional tests can predict the onset of diabetes after transplantation.
Why it matters
Potential benefit: If successful, this study could help identify patients at high risk for diabetes after liver transplantation, allowing for targeted interventions.
How similar studies have gone: While there have been studies on diabetes risk in transplant patients, this specific approach using advanced monitoring techniques is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients presenting to liver transplant clinic with a diagnosis of cirrhosis. * Age \>18 yrs. * Ability to understand and sign written consent form, or have a legally-authorized representative or proxy who can be approached for consent Exclusion Criteria: * Patients without consent * Patients with implantable cardioverter defibrillator devices or automated implantable cardioverter defibrillator devices will be excluded from the bio-electrical impedance analysis portion of the measurements. * Patients with unremovable electrical medical devices or devices that cannot turn off will be excluded from the bio-electrical impedance analysis measurements * Pregnant patients * Incarcerated patients * Patients with a history of type 2 diabetes mellitus diagnosed \> 5 years ago will be excluded from the Oral Glucose Tolerance Test portion of the study
Where it's running
-
University of Chicago Medical Center
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Alan L Hutchison, MD PhD — University of Chicago
- Study coordinator: Alan L Hutchison, MD PhD
- Email: Alan.Hutchison@uchicagomedicine.org
- Phone: 773-702-1000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transplanting abdominal wall tissue to repair defects
This study is testing if transplanting abdominal wall tissue can safely fix defects in the abdominal area for people who need it.
-
Non-invasive methods to diagnose complications after liver transplantation
This study is testing new, non-invasive ways to spot complications early in people who have had a liver transplant to help improve their recovery.
-
Bile acid and gut microbiota changes in people with hepatitis D starting bulevirtide
This project will see if starting bulevirtide changes bile acids and gut bacteria in adults with chronic hepatitis D who are already on hepatitis B therapy.
-
Linking autonomic nervous system function to acute graft-versus-host disease
This study tests whether monitoring autonomic nervous system (ANS) function can help detect acute graft-versus-host disease early in patients receiving HLA-haploidentical transplants.
-
Diagnosing lymphohistiocytic hemophagocytosis in intensive care patients with liver disease
This study will test whether the HScore can accurately detect lymphohistiocytic hemophagocytosis in adults with hepatocellular insufficiency or cirrhosis admitted to intensive care.
-
Echocardiography-guided intensive care for septic shock in people with cirrhosis
This study will try using bedside ultrasound (POCUS) to guide fluid and blood-pressure treatment in adults with cirrhosis who develop sepsis-related low blood pressure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.